Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction

AIMS: Ivabradine and sacubitril/valsartan are second‐line therapies for patients with heart failure and reduced ejection fraction (HFrEF) based on guideline recommendations. We aimed to evaluate the synergistic effects of these two medications. METHODS AND RESULTS: Patients' data were extracted...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ying‐Hsiang, Lin, Po‐Lin, Chiou, Wei‐Ru, Huang, Jin‐Long, Lin, Wen‐Yu, Liao, Chia‐Te, Chung, Fa‐Po, Liang, Huai‐Wen, Hsu, Chien‐Yi, Chang, Hung‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006660/
https://www.ncbi.nlm.nih.gov/pubmed/33410280
http://dx.doi.org/10.1002/ehf2.13182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006660/
https://www.ncbi.nlm.nih.gov/pubmed/33410280
http://dx.doi.org/10.1002/ehf2.13182

Ejemplares similares